Omnicell, Inc. (OMCL) |
| 51.39 0.2 (0.39%) 01-13 16:00 |
| Open: | 51.84 |
| High: | 55 |
| Low: | 50.37 |
| Volume: | 282,168 |
| Market Cap: | 2,380(M) |
| PE Ratio: | 119.51 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 64.24 |
| Resistance 1: | 55.00 |
| Pivot price: | 47.42 |
| Support 1: | 45.22 |
| Support 2: | 39.18 |
| 52w High: | 55 |
| 52w Low: | 22.66 |
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
| EPS | 0.430 |
| Book Value | 27.210 |
| PEG Ratio | 0.00 |
| Gross Profit | 11.498 |
| Profit Margin (%) | 1.69 |
| Operating Margin (%) | 2.65 |
| Return on Assets (ttm) | 0.5 |
| Return on Equity (ttm) | 1.6 |
Tue, 13 Jan 2026
All You Need to Know About Omnicell (OMCL) Rating Upgrade to Buy - Yahoo Finance
Tue, 13 Jan 2026
Healthcare tech firm Omnicell to share 2025 results in Feb. 5 webcast - Stock Titan
Thu, 08 Jan 2026
Omnicell (OMCL) Receives Upgrade to Overweight by Keybanc | OMCL Stock News - GuruFocus
Thu, 08 Jan 2026
Omnicell stock upgraded at KeyBanc (OMCL:NASDAQ) - Seeking Alpha
Thu, 08 Jan 2026
Omnicell (OMCL) Receives Upgrade Amid Promising Growth Potential - GuruFocus
Wed, 07 Jan 2026
Is Omnicell (OMCL) Fairly Priced After Recent Share Price Recovery? - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |